Considering commercialization is a primary goal of the project; there has been an ongoing development of a business plan strategy lead by the partner country to promote the viability of the project contemplating both technical and economic aspects. The UK based workshop on December 2017 and the seminar on Mexico in March 2018 allows for a transfer of knowledge that promotes research in the partner country. This interaction among the partners provides the groundwork for new strategic research projects capable of further stimulate the development of new projects in the biomedical field.
Besides this catalyst effect, DIROBONE has created already two streams of impact:
- Innovative technologies that benefit the strategic manufacturing sectors directly in the partner country, providing a substantial economic boost due to the development of high-value products.
- The reduction of the manufacturing costs that will enable the production of affordable devices to low-income sectors of the population.